Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in China

CompletedOBSERVATIONAL
Enrollment

764

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2015

Conditions
Lung Neoplasms
Trial Locations (6)

100730

Peking Union Medical College Hospital, Beijing

200032

Shanghai Zhongshan Hospital, Shanghai

210002

Nanjing PLA General Hospital, Nanjing

310003

First Affiliated Hospital of Zhejiang University, Hangzhou

400037

Third Military Medical University, Chongqing

450000

Henan Provincial Hospital, Zhengzhou

All Listed Sponsors
collaborator

Shanghai Zhongshan Hospital

OTHER

collaborator

Peking Union Medical College Hospital

OTHER

collaborator

Nanjing PLA General Hospital

OTHER

collaborator

Third Military Medical University

OTHER

collaborator

First Affiliated Hospital of Zhejiang University

OTHER

collaborator

Henan Provincial People's Hospital

OTHER

lead

Bai Chunxue

OTHER

NCT01928836 - Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in China | Biotech Hunter | Biotech Hunter